# POINT BIOPHARMA GLOBAL INC (PNT)

> Institutional ownership reported to the SEC as of Q4 2023, from Form 13F filings. Source: https://holderbook.com/stocks/PNT/

- Reporting holders: 5
- Reported value: $8.6M
- Held through calls: 99.5%
- Held through puts: 0.5%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [LMR Partners LLP](https://holderbook.com/funds/1578621-lmr-partners-llp/) | $6.5M | 0 | 0.1% | 1 |
| [JET CAPITAL INVESTORS L P](https://holderbook.com/funds/1278235-jet-capital-investors-l-p/) | $2.1M | 0 | 4.1% | 1 |
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $9.0K | 0 | 0.0% | 1 |
| [CLEAR STREET MARKETS LLC](https://holderbook.com/funds/1531593-clear-street-markets-llc/) | $4.0K | 0 | 0.0% | 1 |
| [Blue Trust, Inc.](https://holderbook.com/funds/1856022-blue-trust-inc/) | $1.0K | 127 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2023 | 5 | $8.6M |
| Q3 2023 | 129 | $415.4M |
| Q2 2023 | 132 | $571.4M |
| Q1 2023 | 114 | $455.1M |
| Q4 2022 | 107 | $445.5M |
| Q3 2022 | 104 | $470.4M |
| Q2 2022 | 83 | $330.5M |
| Q1 2022 | 68 | $318.0M |
| Q4 2021 | 55 | $201.1M |
| Q3 2021 | 34 | $247.7M |